Hyliion Holdings Corp. (NYSE:HYLN – Free Report) – Equities researchers at Northland Capmk decreased their Q3 2025 earnings per share estimates for Hyliion in a report released on Wednesday, August 20th. Northland Capmk analyst E. Jackson now anticipates that the company will earn ($0.08) per share for the quarter, down from their prior forecast of ($0.07). The consensus estimate for Hyliion’s current full-year earnings is ($0.28) per share. Northland Capmk also issued estimates for Hyliion’s Q4 2025 earnings at ($0.08) EPS, FY2025 earnings at ($0.34) EPS, Q3 2026 earnings at ($0.09) EPS, Q4 2026 earnings at ($0.10) EPS, FY2026 earnings at ($0.35) EPS and FY2027 earnings at ($0.34) EPS.
A number of other research analysts have also commented on the company. Wall Street Zen upgraded Hyliion from a “sell” rating to a “hold” rating in a report on Saturday, August 16th. Zacks Research upgraded Hyliion from a “strong sell” rating to a “hold” rating in a report on Wednesday, August 13th. Two equities research analysts have rated the stock with a Hold rating, According to MarketBeat.com, the company has a consensus rating of “Hold”.
Hyliion Stock Up 11.4%
Shares of HYLN stock opened at $1.76 on Friday. Hyliion has a 12 month low of $1.11 and a 12 month high of $4.0950. The firm has a market cap of $307.68 million, a PE ratio of -4.76 and a beta of 2.73. The stock has a 50 day moving average of $1.52 and a 200-day moving average of $1.56.
Insiders Place Their Bets
In related news, Director Richard Joseph Freeland purchased 65,000 shares of the stock in a transaction on Thursday, August 21st. The shares were purchased at an average cost of $1.57 per share, for a total transaction of $102,050.00. Following the completion of the transaction, the director directly owned 222,798 shares of the company’s stock, valued at approximately $349,792.86. The trade was a 41.19% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 20.90% of the stock is owned by company insiders.
Institutional Trading of Hyliion
A number of hedge funds and other institutional investors have recently made changes to their positions in HYLN. Millennium Management LLC increased its stake in shares of Hyliion by 27.4% in the first quarter. Millennium Management LLC now owns 6,295,760 shares of the company’s stock valued at $8,814,000 after buying an additional 1,355,951 shares in the last quarter. Invesco Ltd. increased its stake in shares of Hyliion by 43.6% in the first quarter. Invesco Ltd. now owns 2,678,501 shares of the company’s stock valued at $3,750,000 after buying an additional 813,593 shares in the last quarter. 683 Capital Management LLC boosted its holdings in Hyliion by 171.4% in the first quarter. 683 Capital Management LLC now owns 950,000 shares of the company’s stock valued at $1,330,000 after acquiring an additional 600,000 shares during the last quarter. Nuveen LLC bought a new position in Hyliion in the first quarter valued at about $811,000. Finally, Dimensional Fund Advisors LP boosted its holdings in Hyliion by 628.8% in the fourth quarter. Dimensional Fund Advisors LP now owns 513,927 shares of the company’s stock valued at $1,335,000 after acquiring an additional 443,412 shares during the last quarter. 22.81% of the stock is currently owned by institutional investors and hedge funds.
About Hyliion
Read More
- Five stocks we like better than Hyliion
- How Can Investors Benefit From After-Hours Trading
- Royal Caribbean Earnings Beat Fuels Strong 2025 Outlook
- Consumer Discretionary Stocks Explained
- Alphabet’s Breakout Potential: From Laggard to AI Leader
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- TJX Stock Price Hits Fresh High, Signals More Highs to Follow
Receive News & Ratings for Hyliion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hyliion and related companies with MarketBeat.com's FREE daily email newsletter.